InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Comparison of the effects of CYT107 vs Placebo administered by intra-muscular route (IM) at 10μg/kg twice a week for three weeks on immune reconstitution of lymphopenic COVID-19 patients
Epistemonikos ID: e1ac55e74bab7f124abf3fc34d478101498db693
First added on: Jun 16, 2021